Cite
HARVARD Citation
Li, W. et al. (2022). Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report. Human vaccines & immunotherapeutics. 18 (6), p. . [Online].